In a new study, researchers explored experiences, perceptions, and health effects of a newly developed healthy lifestyle ...

Members of the Systemic Lupus Erythematosus International Collaborating Clinics (SLICC) group along with experienced ...

Patients with cutaneous lupus erythematosus who used hydroxychloroquine had a significantly reduced risk of developing systemic lupus erythematosus.

A minimum of 3 years of sustained clinical remission may protect against an increase in disease activity and the development ...

Twice-daily deucravacitinib 3 mg and 6 mg significantly improved cutaneous lupus erythematosus activity by week 16, according ...

New research suggests the use of oral prednisone should be limited in patients with systemic lupus erythematosus with a history of recurrent pericarditis.

Researchers identified 4 prepregnancy conditions that were associated with better pregnancy outcomes among patients with SLE.

Medicare covers lupus treatment in different ways depending on your age and how the condition affects you. Read more.

Received Clearance from the U.S. Food and Drug Administration (FDA) for Clinical Trials of Budoprutug in Primary Membranous Nephropathy (pMN), ...

Baseline factors linked to SLE flares during pregnancy included thrombocytopenia and a history of LN, while antimalarial therapy demonstrated protective effects.

Nkarta is laying off a third of its employees, including half of the biotech’s executive leadership, as the company diverts ...

Stock analysts at HC Wainwright increased their Q1 2025 earnings per share estimates for Artiva Biotherapeutics in a research note issued on Wednesday, March 26th. HC Wainwright analyst E. White now ...